Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients

标题
Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients
作者
关键词
anemia, erythropoiesis-stimulating agent, ferric pyrophosphate citrate, hemodialysis, iror
出版物
KIDNEY INTERNATIONAL
Volume 88, Issue 5, Pages 1187-1194
出版商
Elsevier BV
发表日期
2015-07-08
DOI
10.1038/ki.2015.203

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started